Deutsche Bank
VIVO

Deutsche Bank’s Meridian Bioscience Inc VIVO Stock Holding History

Deutsche Bank’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-63,388
Closed -$2.11M – 4072
2022
Q4 		$2.11M Sell
63,388
-63,800
-50% -$2.05M ﹤0.01% 1625
2022
Q3 		$4.01M Buy
127,188
+102,599
+417% +$3.32M ﹤0.01% 1297
2022
Q2 		$748K Sell
24,589
-1,746
-7% -$47.2K ﹤0.01% 2354
2022
Q1 		$684K Sell
26,335
-57,840
-69% -$1.38M ﹤0.01% 2570
2021
Q4 		$1.72M Buy
84,175
+56,630
+206% +$1.09M ﹤0.01% 2087
2021
Q3 		$530K Sell
27,545
-793
-3% -$15.8K ﹤0.01% 2990
2021
Q2 		$629K Sell
28,338
-2,425
-8% -$51.4K ﹤0.01% 3071
2021
Q1 		$807K Sell
30,763
-3,436
-10% -$81.7K ﹤0.01% 2807
2020
Q4 		$639K Buy
34,199
+7,765
+29% +$145K ﹤0.01% 2743
2020
Q3 		$449K Buy
26,434
+2,450
+10% +$47.6K ﹤0.01% 2701
2020
Q2 		$559K Sell
23,984
-281,754
-92% -$4.08M ﹤0.01% 2565
2020
Q1 		$2.57M Sell
305,738
-42,970
-12% -$362K ﹤0.01% 1570
2019
Q4 		$3.4M Buy
348,708
+268,397
+334% +$2.52M ﹤0.01% 1665
2019
Q3 		$759K Sell
80,311
-35,444
-31% -$374K ﹤0.01% 2469
2019
Q2 		$1.37M Sell
115,755
-48,353
-29% -$582K ﹤0.01% 2631
2019
Q1 		$2.89M Buy
164,108
+43,527
+36% +$724K ﹤0.01% 2232
2018
Q4 		$2.09M Sell
120,581
-149,729
-55% -$2.55M ﹤0.01% 2367
2018
Q3 		$4.03M Sell
270,310
-124,439
-32% -$1.93M ﹤0.01% 2368
2018
Q2 		$6.28M Sell
394,749
-117,842
-23% -$1.76M ﹤0.01% 2130
2018
Q1 		$7.28M Buy
512,591
+91,237
+22% +$1.35M ﹤0.01% 1896
2017
Q4 		$5.9M Buy
421,354
+224,359
+114% +$3.28M ﹤0.01% 1889
2017
Q3 		$2.81M Buy
196,995
+47,784
+32% +$683K ﹤0.01% 2314
2017
Q2 		$2.35M Buy
149,211
+18,650
+14% +$269K ﹤0.01% 2452
2017
Q1 		$1.8M Sell
130,561
-46,969
-26% -$657K ﹤0.01% 2311
2016
Q4 		$3.14M Sell
177,530
-8,763
-5% -$154K ﹤0.01% 1969
2016
Q3 		$3.59M Buy
186,293
+59,459
+47% +$1.16M ﹤0.01% 1971
2016
Q2 		$2.47M Buy
126,834
+29,083
+30% +$570K ﹤0.01% 2260
2016
Q1 		$2.01M Sell
97,751
-68,125
-41% -$1.34M ﹤0.01% 2362
2015
Q4 		$3.4M Sell
165,876
-41,955
-20% -$804K ﹤0.01% 2075
2015
Q3 		$3.55M Buy
207,831
+67,912
+49% +$1.24M ﹤0.01% 2047
2015
Q2 		$2.61M Buy
139,919
+36,713
+36% +$681K ﹤0.01% 2250
2015
Q1 		$1.97M Sell
103,206
-214,119
-67% -$3.96M ﹤0.01% 2454
2014
Q4 		$5.22M Buy
317,325
+74,225
+31% +$1.27M ﹤0.01% 1924
2014
Q3 		$4.3M Buy
243,100
+43,142
+22% +$848K ﹤0.01% 1944
2014
Q2 		$4.13M Sell
199,958
-74,132
-27% -$1.52M ﹤0.01% 1956
2014
Q1 		$5.97M Buy
274,090
+156,162
+132% +$3.58M ﹤0.01% 1680
2013
Q4 		$3.13M Sell
117,928
-25,485
-18% -$626K ﹤0.01% 2035
2013
Q3 		$3.39M Buy
143,413
+95,712
+201% +$2.24M ﹤0.01% 2105
2013
Q2 		$1.02M Buy
+47,701
New +$1.03M ﹤0.01% 2677

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's VIVO Position: Q1 2023 in Review

Deutsche Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 63,388 shares — an estimated $2.11M sold.

Deutsche Bank first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $7.28M in Q1 2018. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Deutsche Bank reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Deutsche Bank sold 63,388 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.11M.
  • Deutsche Bank first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Deutsche Bank's Meridian Bioscience Inc position peaked at $7.28M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.